Tregs CD25 CXCL9 in Vitiligo

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2026

Conditions
VitiligoCD25 DeficiencyChemokine (C-X-C Motif)Tregs
Interventions
DIAGNOSTIC_TEST

ELIZA , Flowcytometry

CD25 , CXCL9 by ELISA. T cell population , T regulatory cells by Flow cytometry.

All Listed Sponsors
lead

Assiut University

OTHER

NCT05569096 - Tregs CD25 CXCL9 in Vitiligo | Biotech Hunter | Biotech Hunter